Altimmune
ALT
88 hedge funds and large institutions have $90.1M invested in Altimmune in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 6 closing their positions.
450% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 6
450% more call options, than puts
Call options by funds: $154K | Put options by funds: $28K
222% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 9
42% more funds holding
Funds holding: 62 → 88 (+26)
20% more capital invested
Capital invested by funds: $75.1M → $90.1M (+$15M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$8.46M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.57M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.45M |
| 5 |
Two Sigma Investments
New York
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$14.1M |
| 2 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
-$4.41M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$3.07M |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$334K |
| 5 |
SG Americas Securities
New York
|
-$63K |
ALT Hedge Fund Activity: Q4 2016 in Review
88 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2016, worth a combined $90.1M — up 20% from $75.1M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ALT positions and 6 closed out — a net gain of 27 holders — while 29 added to existing stakes and 9 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $8.46M. The largest seller was Prescott Group Capital Management, cutting an estimated $14.1M.
- 88 institutional investors held Altimmune (ALT) as of Q4 2016, up from 62 in Q3 2016.
- Funds reported $90.1M of Altimmune stock for Q4 2016, up 20% quarter-over-quarter.
- 33 funds opened new Altimmune positions in Q4 2016 and 6 closed out, a net change of +27 holders.
- The largest Altimmune buyer in Q4 2016 was Renaissance Technologies, an estimated $8.46M added.
- The largest Altimmune seller in Q4 2016 was Prescott Group Capital Management, an estimated $14.1M sold.
Based on aggregated 13F filings for Q4 2016.